537 filings
Page 5 of 27
8-K
xgnohca842v5
7 Apr 21
Other Events
5:23pm
424B7
jx84t4vg
7 Apr 21
Prospectus with selling stockholder info
5:20pm
8-K
euk3mq8
24 Mar 21
NeoGenomics Agrees to Acquire Trapelo Health
4:45pm
8-K
lu8q2vx49
1 Mar 21
Departure of Directors or Certain Officers
4:45pm
8-K
yqyfl76
25 Feb 21
Regulation FD Disclosure
5:08pm
8-K
6sbc2e
24 Feb 21
NeoGenomics Reports 18% Revenue Growth to $126 Million
7:51am
8-K
4kiw rcv17v8cruqfp
11 Jan 21
Regulation FD Disclosure
5:16pm
8-K
r70nkd5189
11 Jan 21
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:13pm
424B5
tqjb9oimus6sbxnzc7ap
8 Jan 21
Prospectus supplement for primary offering
2:17pm
424B5
2aypvpup6
8 Jan 21
Prospectus supplement for primary offering
2:15pm
FWP
rk1v5d ivxgj
7 Jan 21
Free writing prospectus
7:02am
424B5
3jczr2
5 Jan 21
Prospectus supplement for primary offering
4:08pm
S-3ASR
ywekfv8 uxta
5 Jan 21
Automatic shelf registration
4:05pm
8-K
8690opodlbsf2e u1
5 Jan 21
Other Events
4:01pm
8-K
iz7ex
29 Oct 20
Regulation FD Disclosure
5:19pm
8-K
j57960dp62h5z
27 Oct 20
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million
7:59am
8-K
klag5ez2
31 Jul 20
INVESTOR PRESENTATION July 2020
5:10pm